Data-informed overdose prevention in illinois - the illinois department of public health (idph) is submitting this proposal, data-informed overdose prevention in illinois (IL) in response to…

Data-informed overdose prevention in illinois - the illinois department of public health (idph) is submitting this proposal, data-informed overdose prevention in illinois (IL) in response to CDC-RFA-CE-0002-OD2A in states with the goal of decreasing drug-related harms throughout the state. Preliminary 2022 data report 3,711 overdose deaths in IL, with increases in overdoses due to xylazine (42%), cocaine (11%), and synthetic opioids (4%) and decreases in overdose deaths due to heroin (32% decrease), psychostimulants (10%) compared to 2021. The proposal includes surveillance and prevention activities under the following strategies: S1: expand the IL opioid data dashboard; create and test a protocol for large scale emergency response for overdoses; expand the cross-sector data workgroup on overdoses; and develop an API for medical examiner data transfer. S2: submit monthly ED syndromic surveillance (sys) data; provide a yearly line-list dataset: release 2+ timely data products that include non-fatal overdose data from sys or hospital discharge data (HDD); achieve 100% hospital independent reporting of overdose counts; expand technical assistance for local health departments; S3: collect data on IL unintentional drug overdose death from death certificates, coroner/medical examiner (c/me) and toxicology reports and enter sudors data into the CDC's data entry system; submit data following reporting periods; improve sudors data quality; disseminate sudors data/products; support expanded toxicological testing through c/me; S4: continue and expand upon pilot site collecting biowaste urine specimens, pre-screen for fentanyl, and if positive send to NMS laboratory for an extended novel psychoactive substances panel testing; aggregate data from all sites and disseminate to stakeholders; provide DE-identified data for patient and lab results. S5: assign an MPI to sys records to perform person-level analysis of repeat visits for reasons prior to an overdose; link vital records death data to the HDD and sys ED records for non-fatal overdose at the person-level; link deaths since 01/01/22 to all non-fatal ED visits that occurred any time in the previous year+ before a death. During previous OD2A funding, idph linked HDD ED visits and PMP records and will continue during this funding period; HDD visit data or death data will be linked to the social vulnerability index at the county level for overdose data from 2018 forward. S6: use PMP outreach/vendor support to provide training and increase prescriber adherence to c DC guidelines on pain management; expand PMP data sharing across state lines/interstate interoperability; improve PMP ease of access and use; broaden connections with behavioral, physical, and pharmacy providers through new training coordinator position at idph; provide grant opportunity for linkage to care learning collaborative and improve ED utilization of best practices for screening, diagnosing SUD and linkages to care and expanding opportunities to incorporate certified recovery support specialists and other navigators. S7: create infrastructure for documentation, operationalization, and expansion of overdose fatality review teams; increase review of overdoses by multi-disciplinary teams; increase outreach regarding trends identified and gaps in service provision. S8: expand the block by block initiative. S9:expand use of crss/navigators to facilitate linking people to care and other services; train use of reversal medications and harm reduction strategies for drugs circulating; support retention in care via telehealth/direct client interactions. A robust evaluation will capture process/outcome measures to guide continuous improvement. Following the OD2A data to action framework, IL will prioritize the highest drug overdose burdens to implement interventions. Idph and its partners have learned a great deal through previous OD2A, federal, and state-funded projects. Partners remain committed to the integration of state and local response to reduce drug-related harms in IL